Related tags
Connection Vol. 12: Pharmacodiagnostics
Discusses the topic of pharmacodiagnostics - also known as companion diagnostics or pharmDx, which is the shorter Dako term - used to describe “a pre-treatment measurement performed to aid in the assessment of whether a patient is likely to respond to a given drug or not”.
Download the full Connection Vol. 12
Literature Order No. 28827
All articles that have been brought in Connection 12 are available below:
Connection 12 Articles
-
3D Fluorescence in situ Hybridization (FISH)
Dec 01, 2008
-
Milestones in the Discovery of HER2 Proto-Oncogene and Trastuzumab (Herceptin™)
Dec 01, 2008
-
Targeted Therapy of Her2/neu Mediated Tumors
Dec 01, 2008
-
Interview with Prof. Giuseppe Viale
Dec 01, 2008
-
The HER Gene Family and Pharmacodiagnostics (Companion Diagnostics): A Tale of Two Targets
Dec 01, 2008
-
Pharmacodiagnostic and Personalized Medicine
Dec 01, 2008
-
Pharmacodiagnostic in Breast Cancer
Dec 01, 2008
-
Topoisomerase II Alpha and Chemotherapy Selection for Breast Cancer
Dec 01, 2008
-
Pre-analytic Variables, Breast Cancer Testing and Adjuvant Treatment Planning for Patients Diagnosed with Breast Cancer
Dec 01, 2008
-
EGFR FISH Assay as a Predictive Factor in Lung Adenocarcinoma and / or Metastatic Colorectal Carcinoma
Dec 01, 2008
-
ASCO-CAP HER2 Testing Guidelines and Validation Studies*
Dec 01, 2008
-
Biomarkers for Therapeutic Efficacy•
Dec 01, 2008
-
Reporting of Tumor Marker Studies
Dec 01, 2008
-
Difference of Biomarker Expression Among Primary Tumor and Brain Metastasis: a Report of Immunohistochemical Profiles of Resected Brain Metastases from Breast Cancer
Dec 01, 2008
-
IHC Bio-Marker, Development, Testing and Commercialization in the United States: A Personal Perspective
Dec 01, 2008
-
Experience with a Molecular-friendly Histology System for Preservation of Biomolecules in Breast Cancer Tissue
Dec 01, 2008
-
28827_2008_conn12_FISH_Imaging_Kumar_and_Zucker.pdf
Dec 01, 2008